Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis

Meghna Jani; Hector Chinoy; Richard B. Warren; Christopher Em Griffiths; Darren Plant; Ann W Morgan; Anthony G. Wilson; Kimme L Hyrich; John D. Isaacs; Anne Barton

doi:10.1016/s0140-6736(15)60363-4

Back

Shared by

Christopher Em Griffiths

Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis

Article 2015 en

Authors

MJ
Meghna Jani
HC
Hector Chinoy
RW
Richard B. Warren

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2015

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

Meghna Jani, Hector Chinoy, Richard B. Warren, Christopher Em Griffiths, Darren Plant, Bo Fu, Ann W Morgan, Anthony G. Wilson, John D. Isaacs, Kimme L Hyrich, Anne Barton

Letter2009

Graves’ Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy

Jae Il Shin, Min Jung Kim, Jae Seung Lee

Article2014

Effect of immunogenicity on efficacy of long-term treatment of rheumatoid arthritis with adalimumab

Meghna Jani, Hector Chinoy, Richard B. Warren, Christopher Em Griffiths, Anne Barton

Article2017

Long-term dietary quality and risk of developing rheumatoid arthritis in women

Yang Hu, Jeffrey A. Sparks, Susan Malspeis, Karen H. Costenbader, Frank B Hu, Elizabeth W. Karlson, Bing Lü

Article2014

SAT0052 Influence of Immunogenicity and Drug Levels on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab and Etanercept: A Uk-Based Prospective Study

Meghna Jani, Hector Chinoy, Richard B. Warren, Bo Fu, Christopher Em Griffiths, Ann W Morgan, G. M. Wilson, Kimme L Hyrich, John D. Isaacs, Anne Barton